However, like any supplement, improper dosage or pre-existing conditions may lead to minor side effects
Phase 2 clinical trials started at 2mg
What's Next: Orforglipron (oral GLP-1) completing Phase 3 trials with submissions expected by year-end 2025 CEO Dave Ricks expects FDA approval by March 2026 International launches accelerating in China, Brazil, India, and Mexico The GLP-1 market is projected to exceed $100B+ by the early 2030s, and Lilly is positioned as the category leader
This color comes entirely from the B12 component, specifically cyanocobalamin, which has a naturally occurring red-pink pigment at the molecular level
This neurological effect, rather than stimulation or restriction, makes semaglutide a gentler option for mature patients who have tried multiple diets without lasting success